Abstract
Background Identify risk factors for repeat hospitalisation involving self-harm by Aboriginal and non-Aboriginal people in the Northern Territory (NT), Australia.
Methods A retrospective cohort study of hospitalisations involving suicidal ideation and/or self-harm between 1 July 2001 and 31 December 2013 followed up to 31 December 2018. Survival analyses identified demographic and clinical characteristics associated with repeat hospitalisation involving self-harm.
Results The risk of repeat hospitalisation involving self-harm was higher (HR 1.39; 95% CI: 1.22-1.59) amongst Aboriginal (n=2,304) than non-Aboriginal people (n=2,087). Compared to suicidal ideation only, a higher risk of repetition was observed for any self-harm method (aHR: 1.71; 95% CI: 1.37-2.12) amongst Aboriginal people and self-poisoning only (aHR: 1.45; 95% CI: 1.13-1.85) amongst non-Aboriginal people. Previous substance misuse was associated with a higher risk of repeat hospitalisation involving self-harm for Aboriginal (aHR: 1.7; 95% CI: 1.38-2.1) and non-Aboriginal (aHR: 1.6; 95% CI: 1.14-2.25) people. For non-Aboriginal people, several mental health diagnoses were associated with higher risks of repetition.
Limitations The use of routinely collected administrative data limits analysis to only coded diagnoses and does not represent the full burden of self-harm and suicidal ideation in hospitals.
Conclusion The similarities and differences in long-term risk of repeat hospitalisation involving self-harm between Aboriginal and non-Aboriginal people pose distinct challenges for clinical management and prevention. The results emphasise the importance of comprehensive psychosocial assessment to properly understand the interplay of individual and contextual influences and highlights the need to better understand the availability and effectiveness of culturally tailored clinical interventions and community-based solutions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BL was provided a research scholarship from the National Suicide Prevention Research Fund administered by Suicide Prevention Australia to undertake this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human and Research Ethics Committees of the NT Department of Health and Menzies School of Health Research gave ethical approval for this work (Ref: 15-392)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in the present study is not available outside of the investigators named on ethics approvals as per the conditions set by the owners/custodians of the data.
